HCD Launches Tool to Analyse Pharma Sentiment

In the US, HCD Research has launched a syndicated service to help pharma marketers qualitatively understand the sentiments of consumers and physicians towards their and their competitors' brands.

The firm's new NetClassRX solution uses proprietary algorithms to sift through conversations on web sites, forums, blogs and social networks. The extracted data is analyzed in aggregate and reported through a dashboard, which allows marketers to view consumer sentiment on a daily basis, and physician sentiment monthly or quarterly. The ratio of positive or negative comments can then be quantified for each product in a class of drugs.

'The service allows brand managers to view their brands' health on-line and compare it to the health of competitor brands on a daily basis using a summary dashboard which is supported by detailed reports,' explains President and CEO Glenn Kessler. 'It also allows them to detect rumors and determine the impact of new product claims and other news related to their brand within 24 hours.'

Headquartered in Flemington, NJ, HCD Research provides traditional and web-based marketing and communications research. Yesterday, the firm announced that it has partnered with Muhlenberg College Institute of Public Opinion (MCIPO) to measure voter sentiment in the run up to the forthcoming fall elections.

Web site: www.hcdi.net .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• HCD Research
• All news